Sean Wieland
Stock Analyst at Piper Sandler
(1.81)
# 3,287
Out of 5,182 analysts
31
Total ratings
45.45%
Success rate
0.42%
Average return
Main Sectors:
Stocks Rated by Sean Wieland
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OMCL Omnicell | Maintains: Overweight | $57 → $55 | $34.15 | +61.05% | 12 | Aug 11, 2025 | |
| PRVA Privia Health Group | Maintains: Overweight | $35 → $36 | $21.21 | +69.73% | 3 | Aug 11, 2025 | |
| AMWL American Well | Maintains: Overweight | $100 → $120 | $5.50 | +2,081.82% | 2 | Jun 23, 2022 | |
| HIMS Hims & Hers Health | Maintains: Overweight | $8 → $6 | $19.14 | -68.65% | 3 | May 26, 2022 | |
| DOCS Doximity | Maintains: Overweight | $81 → $44 | $22.77 | +93.24% | 2 | May 19, 2022 | |
| IQV IQVIA Holdings | Maintains: Neutral | $261 → $231 | $173.26 | +33.33% | 4 | Feb 18, 2022 | |
| TDOC Teladoc Health | Maintains: Overweight | $305 → $291 | $5.27 | +5,421.82% | 5 | Feb 25, 2021 |
Omnicell
Aug 11, 2025
Maintains: Overweight
Price Target: $57 → $55
Current: $34.15
Upside: +61.05%
Privia Health Group
Aug 11, 2025
Maintains: Overweight
Price Target: $35 → $36
Current: $21.21
Upside: +69.73%
American Well
Jun 23, 2022
Maintains: Overweight
Price Target: $100 → $120
Current: $5.50
Upside: +2,081.82%
Hims & Hers Health
May 26, 2022
Maintains: Overweight
Price Target: $8 → $6
Current: $19.14
Upside: -68.65%
Doximity
May 19, 2022
Maintains: Overweight
Price Target: $81 → $44
Current: $22.77
Upside: +93.24%
IQVIA Holdings
Feb 18, 2022
Maintains: Neutral
Price Target: $261 → $231
Current: $173.26
Upside: +33.33%
Teladoc Health
Feb 25, 2021
Maintains: Overweight
Price Target: $305 → $291
Current: $5.27
Upside: +5,421.82%